Drugs / [18F]FPyGal
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04536454 | Apr 2021 → Jun 2023 | cancer | University Hospital Tuebingen | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]FPyGal | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04536454 ↗ |
| Modality | Diagnostic / imaging agent | “Radiotracer for PET-imaging” NCT04536454 ↗ |